Basic/Clinical Science Session
Preserving the Tuft: New Concepts in Glomerular Disease Therapeutics, Including the Michelle P. Winn, MD, Endowed Lectureship
October 22, 2020 | 10:30 AM - 12:30 PM
Location: Live-Streamed
Session Description
Therapeutic targets for glomerular disease remain scarce, but recent advances bode well for improved patient outcomes and treatment options in the near future. This session explores emerging concepts in the treatment of glomerular disease with a focus on precision-based approaches.
ASN gratefully acknowledges Duke University School of Medicine, the school's Division of Nephrology, and several individuals for support of the Michelle P. Winn, MD, Endowed Lectureship.
Learning Objective(s)
- Define novel and emerging therapeutic targets for primary glomerular disease
- Describe the specificity, efficacy, and mechanism of action of novel therapeutic agents for glomerular disease
Learning Pathway(s)
- Glomerular Diseases
Moderators
- Dawn J. Caster, MD, FASN
- Rasheed A. Gbadegesin, MD, MBBS, FASN
Presentations
-
Drug Targeting of the Podocyte Actin Cytoskeleton: The Michelle P. Winn, MD, Endowed Lectureship
10:30 AM - 11:00 AM
Mario Schiffer, MD, MBA
-
Targeting Podocyte Histone Deacetylases
11:00 AM - 11:30 AM
Shuta Ishibe, MD
-
Therapeutic Targeting of APOL1: Rationale and Current Strategies
11:30 AM - 12:00 PM
Opeyemi A. Olabisi, MD, PhD
-
Targeting the Complement System in Glomerular Disease: Novel Concepts
12:00 PM - 12:30 PM
Nicole Van De Kar, MD, PhD
